Metoclopramid Polpharma

Metoclopramide Hydrochloride, the active ingredient in Metoclopramid Polpharma, is a dopamine D2 receptor antagonist presented as an injectable solution for intramuscular or intravenous use. It is employed to treat nausea, vomiting, postoperative nausea, migraine‑associated nausea, and gastroparesis in adult patients. GNH USA supplies Metoclopramid Polpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramid Polpharma acts on the dopamine pathway to control emesis and improve gastrointestinal motility. - Nausea and vomiting: reduces the frequency and severity of acute episodes. - Post‑operative nausea and vomiting: prevents nausea after surgical procedures. - Migraine‑associated nausea: alleviates nausea accompanying migraine attacks. - Gastroparesis: enhances gastric emptying and relieves related symptoms.

Metoclopramid Polpharma may cause a range of adverse reactions.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Restlessness: a sense of inner tension or inability to stay still. - Diarrhea: increased loose bowel movements. - Dry mouth: reduced salivation leading to a parched feeling. - Headache: mild to moderate head pain. - Fatigue: general lack of energy.

Serious or Rare Side Effects: - Extrapyramidal symptoms: involuntary muscle movements or rigidity. - Tardive dyskinesia: persistent, irreversible facial or tongue movements. - Neuroleptic malignant syndrome: life‑threatening fever, muscle rigidity, and autonomic instability.

Before using Metoclopramid Polpharma, consider the following safety measures. - Renal or hepatic impairment: assess function and adjust therapy as needed. - Extrapyramidal monitoring: watch for signs of muscle rigidity or abnormal movements. - Lowest effective dose: use the minimal dose required to achieve therapeutic effect. - Hypersensitivity: discontinue if allergic reactions occur. - Elderly patients: increased risk of sedation and falls; monitor closely. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Metoclopramid Polpharma can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - CNS depressants (e.g., opioids, benzodiazepines): may enhance sedation. - Antipsychotics (e.g., haloperidol): increase risk of extrapyramidal reactions. - MAO inhibitors: can potentiate hypertensive responses.

Moderate Interactions (Monitor Closely): - Anticholinergics: may reduce pro‑kinetic efficacy. - CYP2D6 inhibitors (e.g., fluoxetine): may raise metoclopramide plasma levels. - Diabetic agents: monitor blood glucose as metoclopramide can affect glycemic control.